Arctigenin inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways.
Arctigenin, a lignan-derived compound, is a constituent of the seeds of Arctium lappa. Arctigenin was previously shown to inhibit osteoclastogenesis; however, this inhibitory mechanism has yet to be elucidated. Here, we showed that arctigenin inhibited the action of nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), a key transcription factor for osteoclastogenesis. NFATc1 in osteoclast precursors was activated through two distinct pathways: the calcineurin-dependent and osteoblastic cell-dependent pathways. Among the several lignan-derived compounds examined, arctigenin most strongly inhibited receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast-like cell formation in mouse bone marrow macrophage (BMM) cultures, in which the calcineurin-dependent NFATc1 pathway was activated. Arctigenin suppressed neither the activation of nuclear factor κB and mitogen-activated protein kinases nor the up-regulation of c-Fos expression in BMMs treated with RANKL. However, arctigenin suppressed RANKL-induced NFATc1 expression. Interestingly, the treatment of osteoclast-like cells with arctigenin converted NFATc1 into a lower molecular weight species, which was translocated into the nucleus even in the absence of RANKL. Nevertheless, arctigenin as well as cyclosporin A (CsA), a calcineurin inhibitor, suppressed the NFAT-luciferase reporter activity induced by ionomycin and phorbol 12-myristate 13-acetate in BMMs. Chromatin immunoprecipitation analysis confirmed that arctigenin inhibited the recruitment of NFATc1 to the promoter region of the NFATc1 target gene. Arctigenin, but not CsA suppressed osteoclast-like cell formation in co-cultures of osteoblastic cells and bone marrow cells, in which the osteoblastic cell-dependent NFATc1 pathway was activated. The forced expression of constitutively active NFATc1 rescued osteoclastogenesis in BMM cultures treated with CsA, but not that treated with arctigenin. Arctigenin also suppressed the pit-forming activity of osteoclast-like cells cultured on dentin slices. These results suggest that arctigenin induces a dominant negative species of NFATc1, which inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways.
Institute for Oral Science, Matsumoto Dental University, Shiojiri, Nagano, Japan.
Teruhito
T
Yamashita
Department of Biochemistry, Matsumoto Dental University, Shiojiri, Nagano, Japan.
Shunsuke
S
Uehara
Department of Biochemistry, Matsumoto Dental University, Shiojiri, Nagano, Japan.
Nobuyuki
N
Udagawa
Institute of Natural Medicine, University of Toyama, Toyama, Japan.
Feng
F
Li
Institute of Natural Medicine, University of Toyama, Toyama, Japan.
Shigetoshi
S
Kadota
National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Hiroyasu
H
Esumi
Institute for Oral Science, Matsumoto Dental University, Shiojiri, Nagano, Japan.
Yasuhiro
Y
Kobayashi
Institute for Oral Science, Matsumoto Dental University, Shiojiri, Nagano, Japan.
Naoyuki
N
Takahashi
D000818:Animals; D019703:Calcineurin / Q000378:metabolism*; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D018920:Coculture Techniques; D005663:Furans / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D017705:Lignans / Q000737:chemistry / Q000494:pharmacology*; D051379:Mice; D050778:NFATC Transcription Factors / Q000235:genetics / Q000378:metabolism*; D010006:Osteoblasts / Q000187:drug effects / Q000378:metabolism*; D010010:Osteoclasts / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D010012:Osteogenesis / Q000187:drug effects; D021381:Protein Transport / Q000187:drug effects; D053245:RANK Ligand; D015398:Signal Transduction / Q000187:drug effects*; D014158:Transcription, Genetic / Q000187:drug effects
D005663:Furans; D017705:Lignans; D050778:NFATC Transcription Factors; D053245:RANK Ligand; D019703:Calcineurin; C071942:arctigenin